←Back to Expert Scholars
Translational Medicine / 转化医学Actinic Keratosis and Non Melanoma Skin Cancer
Mark Lebwohl
MD
🏢Icahn School of Medicine at Mount Sinai🌐USA
Dean for Clinical Therapeutics
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mark Lebwohl is a leading dermatologist with extensive contributions to actinic keratosis and non melanoma skin cancer therapy. He has helped design and interpret pivotal trials of field directed treatments including tirbanibulin. He is a former president of the American Academy of Dermatology.
Share:
🧪Research Fields 研究领域
actinic keratosis
psoriasis
field therapy
topical therapy
non melanoma skin cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mark Lebwohl 的研究动态
Follow Mark Lebwohl's research updates
留下邮箱，当我们发布与 Mark Lebwohl（Icahn School of Medicine at Mount Sinai）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment